cefaclor anhydrous has been researched along with Pneumonia, Bacterial in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deng, LP; Du, YP; Jiang, XT | 1 |
Hutchison, J; Nolen, TM; Phillips, HL | 1 |
Bianchi, P; Drehobl, M; Griffin, TJ; Keyserling, CH; Tack, KJ | 1 |
de Boisblanc, BP; Haponik, E; Karam, G; Nelson, S; Omidvari, K; Summer, W | 1 |
3 trial(s) available for cefaclor anhydrous and Pneumonia, Bacterial
Article | Year |
---|---|
[Comparative study on cefdinir and cefaclor in the treatment of patients with mild to moderate bacterial community acquired pneumonia].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Humans; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Streptococcal Infections | 2004 |
Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefdinir; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome; United States | 1997 |
Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cefaclor; Cefamandole; Cephalosporins; Community-Acquired Infections; Female; Health Care Costs; Hospitalization; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 1998 |
1 other study(ies) available for cefaclor anhydrous and Pneumonia, Bacterial
Article | Year |
---|---|
A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
Topics: Alabama; Anti-Bacterial Agents; Bronchitis; Cefaclor; Cefuroxime; Clinical Trials as Topic; Community-Acquired Infections; Drug Combinations; Humans; Pneumonia, Bacterial; Reproducibility of Results; Respiratory Tract Infections; Safety; Treatment Failure; Treatment Outcome | 1989 |